B. Pierson

Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor-beta 1 and independent accessory cell-derived contact and soluble factors.

W. S. Hu, Jeffrey S. Miller, J. Miller, 1996, Blood.

The role of autologous natural killer cells in chronic myelogenous leukemia.

J. Miller, B. Pierson, J. Miller, 1997, Leukemia & lymphoma.

Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.

C. Verfaillie, Jeffrey S. Miller, J. Miller, 1996, Blood.

CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis.

J. Miller, B. Pierson, Jeffrey S. Miller, 1996, Blood.

Natural killer cell proliferation is dependent on human serum and markedly increased utilizing an enriched supplemented basal medium.

W. S. Hu, J. Miller, P. Mcglave, 1995, Journal of hematotherapy.

Population dynamics of human activated natural killer cells in culture

C. Verfaillie, Jeffrey S. Miller, P. Mcglave, 1994, Biotechnology and bioengineering.

myelogenous leukemia progenitors in long-term culture Autologous activated natural killer cells suppress primitive chronic

C. Verfaillie, Jeffrey S. Miller, F. Cervantes, 2002 .

Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.

C. Verfaillie, J. Lebkowski, D. Weisdorf, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Production of human natural killer cells for adoptive immunotherapy using a computer-controlled stirred-tank bioreactor.

J. Miller, A. Europa, B. Pierson, 1996, Journal of hematotherapy.

Process Technology in Cellular and Tissue Engineering

Wei-Shou Hu, B. A. Pierson, S. H. Chao, 1994 .